NMN – nicotinamide mononucleotide – is one of the fastest-growing supplements in longevity and biohacking. Andrew Huberman talks about it, Bryan Johnson takes it six days a week, and human research is finally starting to keep pace with the hype. But the market is confusing: NMN, NR, NADH and direct NAD+ are sold side by side without the differences being properly explained.
This guide covers what NMN actually is, how it differs mechanistically from NR and NADH, what human research shows, what novel food status means in practice – and how to dose if you choose to try it. See also our complete guide to NAD+ and NMN for a broader overview of the category.
What is NMN and why does it exist as a supplement?
Nicotinamide mononucleotide (NMN) is a naturally occurring molecule in the body – one of the last building blocks in the synthesis pathway to NAD+ (nicotinamide adenine dinucleotide). NAD+ is a coenzyme found in every cell that drives energy production, DNA repair and sirtuin activation. It declines by approximately 50% between ages 20 and 60.
The problem with taking NAD+ directly by mouth is that the molecule is too large to cross the cell membrane – it breaks down in the intestine before reaching cells. The solution is to provide precursors – precursor molecules that cells can convert to NAD+ from within. NMN is the precursor closest to NAD+ in the synthesis pathway.
Natural NMN sources exist in food: broccoli (~0.25–1.12 mg/100g), avocado (~1–2 mg/100g) and edamame (~0.37–1.65 mg/100g). The amounts are too low for therapeutic effect – a 300 mg capsule corresponds to roughly 15–30 kg of broccoli. Supplements are the only practical route to clinically relevant doses.
How NMN is absorbed – the Slc12a8 transporter
A key question is how NMN actually gets into cells. Early studies suggested NMN was broken down to NR in the bloodstream and then converted back to NMN and finally NAD+ inside the cell – an inefficient detour. Newer research changes that picture.
A study published in Nature Metabolism (Grozio et al., 2019) identified a specific NMN transporter in intestinal epithelial cells: Slc12a8. This transporter takes up NMN directly into cells without needing to break it down to NR first. This means NMN potentially has a more direct route to NAD+ than NR. Whether Slc12a8 is functionally relevant in other human tissues is still under investigation – but the finding strengthens the mechanistic case for NMN.
Practical implication: sublingual NMN (under the tongue) bypasses breakdown in the gastrointestinal tract and is absorbed directly through the oral mucosa. A Japanese RCT (Irie et al., 2020) showed sublingual NMN raised blood NMN levels significantly faster than oral capsules.
NMN vs NR vs NADH – a clear recommendation
NMN (nicotinamide mononucleotide)
One step from NAD+ in the synthesis pathway. Possibly absorbed directly via the Slc12a8 transporter. Backed by strong newer human studies (Huang 2022, Yoshino 2021, Jansson 2026). Novel food grey zone in the EU – sold in Sweden but lacks formal EU authorization for supplements.
NR (nicotinamide riboside)
Two steps from NAD+ – must be converted to NMN before becoming NAD+. Approved novel food in the EU with clear regulatory status. Most well-studied form historically. Comparison study (Jansson 2026, 65 participants) showed NMN and NR performed equally in doubling circulating NAD+ levels in 14 days.
NADH (reduced NAD)
NAD in its reduced form – the form that donates electrons in energy production. Limited human studies and poorer documentation compared to NMN and NR. Not a recommended first-line option for NAD+ elevation.
Direct NAD+
Poor oral bioavailability – breaks down in the intestine. IV infusion is used clinically but is not relevant as a home supplement.
| Form | Steps to NAD+ | EU status | Human studies | Recommendation |
|---|---|---|---|---|
| NMN | 1 step | Grey zone (novel food) | Strong, growing | First choice for NAD+ optimization |
| NR | 2 steps | Approved novel food EU | Most well-studied | Safer regulatory choice |
| NADH | Reduced form | Limited | Limited | Second choice |
| Direct NAD+ | Direct – poor absorption | – | No oral outcome studies | Not recommended orally |
Honest recommendation: NMN and NR perform equivalently on what is actually measured in human studies – the ability to raise circulating NAD+ levels. Choose NMN if you want the form closest to NAD+ in the synthesis pathway and are comfortable with the regulatory grey zone. Choose NR if regulatory clarity matters. Alternate them as Johnson does if budget allows.
Novel food status – what it actually means
This is the information most NMN articles miss – but it is critical for what is legal to buy and sell.
EU novel food regulation (2015/2283) requires that foods or ingredients not consumed in significant amounts in the EU before May 1997 undergo a safety assessment and be approved by EFSA before being sold as supplements.
NR: Approved as novel food in the EU since 2019. Legal to sell as a supplement.
NMN: Classified as novel food but lacks general EU authorization for supplements:
- NMN is sold and can be legally imported for personal use
- Regulatory status varies by country and changes over time
- The Swedish Food Agency has not specifically banned NMN but has not formally approved it either
- Reputable sellers clearly state regulatory status and documentation
Always check that the retailer can provide correct documentation. Status may change – this was written in June 2026.
What human research actually shows about NMN
Huang et al. 2022 – the strongest dose study
Randomized, double-blind, placebo-controlled study with 80 healthy adults. Three dosing groups – 300, 600 and 900 mg/day NMN – compared to placebo for 60 days. All three dose groups showed statistically significant increases in blood NAD+ at days 30 and 60. All 80 participants completed without protocol violations. The dose-response relationship – higher dose, more NAD+ – is strong evidence of a mechanistic effect.
Yoshino et al. 2021 (Science) – clinical relevance
250 mg/day NMN for 10 weeks in overweight premenopausal women with prediabetes. Significant improvement in muscle insulin sensitivity – a clinically relevant outcome, not just a surrogate marker.
Jansson et al. 2026 – NMN vs NR head-to-head
RCT with 65 participants: 1,000 mg/day NMN, NR and nicotinamide (NAM) for 14 days. NMN and NR doubled circulating NAD+ levels equally. NAM did not show the same effect. The most direct head-to-head data available.
Irie et al. 2020 – sublingual NMN
Japanese RCT: sublingual NMN (500 mg) raised blood NMN significantly faster than oral capsules. Bypasses breakdown in the gastrointestinal tract.
| Study | Design | Dose | Main result |
|---|---|---|---|
| Huang et al. 2022 | RCT, 80 participants, 60 days | 300–900 mg/day | Significant NAD+ elevation, dose-response |
| Yoshino et al. 2021 | RCT, 10 weeks | 250 mg/day | Improved muscle insulin sensitivity |
| Jansson et al. 2026 | RCT, 65 participants, 14 days | 1,000 mg/day | NMN = NR, doubled NAD+ levels |
| Irie et al. 2020 | RCT, sublingual | 500 mg | Rapid NMN absorption |
Dosage and protocol
- 250 mg/day: Lowest dose with clinical effect (Yoshino 2021). Good starting dose.
- 300–500 mg/day: Most common range with good evidence.
- 600–900 mg/day: Dose-response effect in Huang 2022. Used by those prioritizing maximum NAD+ elevation.
- Timing: Morning with breakfast – NAD+ is linked to circadian rhythms. Late intake may disrupt sleep.
- Sublingual: Bypasses the gastrointestinal tract for faster absorption. Choose sublingual forms if bioavailability is a priority.
- Cycling: No evidence-based reason to cycle. Daily use is the standard protocol in studies.
Safety and side effects
Huang 2022 showed no serious side effects at 900 mg/day for 60 days. Common mild side effects:
- Stomach discomfort at high doses – minimized by taking with food
- Mild headache during the startup period
- Disrupted sleep if taken late – always take in the morning
- Mild flushing in sensitive individuals – rarer with NMN than with niacin
Contraindications: Pregnant and breastfeeding women, cancer history without medical supervision, liver or kidney disease, diabetes medications or blood thinners – consult a doctor.
NMN in a longevity stack
Bryan Johnson takes NMN as part of his Blueprint protocol – 6 days per week, alternated with NR. He has measured an intracellular NAD+ value of 54.6 μM, within the optimal range of 40–100 μM.
Synergistic combinations:
- NMN + Resveratrol: Classic longevity combination. Resveratrol activates SIRT1 – but SIRT1 requires NAD+ as a cofactor. Our NAD+ Complex contains NAD+ with resveratrol and CoQ10.
- NMN + CoQ10: Supports the mitochondrial respiratory chain from a parallel angle.
- NMN + Lithium Orotate: Mitochondrial energy + neuroprotective effects. See our guide to lithium orotate.
- NMN + Fisetin: Senolytics clear senescent cells, NMN supports the function of remaining cells.
Frequently asked questions
What is the difference between NMN and NR?
NMN is one step from NAD+ and may be absorbed directly via the Slc12a8 transporter. NR must be converted to NMN before becoming NAD+. Human data (Jansson 2026) shows they raise NAD+ levels equally at 1,000 mg/day. NR has clearer EU regulatory status; NMN has stronger recent studies.
Is NMN legal?
NMN is in a regulatory grey zone – classified as novel food in the EU but lacks formal EU authorization for supplements. It is sold and can be legally purchased for personal use. Always check documentation with the retailer.
How long until you notice effects?
Blood NAD+ starts rising within days to weeks. Subjective effects such as increased energy and better recovery are typically reported after 2–4 weeks of consistent use.
What is the optimal NMN dose?
250 mg/day is the lowest clinically effective dose. 300–500 mg/day is the most common range. 600–900 mg/day provides stronger NAD+ elevation according to Huang 2022.
Can you take NMN every day?
Yes. Human studies have used daily dosing without safety signals for up to 60 days. Continuous daily use is the standard protocol.
Can NMN be combined with other supplements?
Yes. The combination with resveratrol, CoQ10, fisetin and creatine is well-established. No known interactions with most supplements. Consult a doctor if taking medications.
Find Noop's NMN product: NMN Sportlab. See also our NAD+ Complex with Resveratrol and CoQ10, the full longevity range and our complete NAD+ guide.